Allogene Therapeutics, Inc.
USD1.79
+0.00 (+0.00%)
CEO
Zachary Roberts
IPO Date
2018-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.74
Prev. Close
$1.79
Day Low
$1.74
Day High
$1.83
52W Low
$0.98
52W High
$4.46
Market Cap
$0.44B
Volume
4.92M
| 476,190 |
| $2.11 |
| 23 Jun 2026 | Kazam Joshua A | director | M-Exempt | Acquired | 47,700 | $0.00 |
| 23 Jun 2026 | Kazam Joshua A | director | M-Exempt | Disposed | 47,700 | $0.00 |
| 23 Jun 2026 | Kazam Joshua A | director | A-Award | Acquired | 95,400 | $0.00 |
| 23 Jun 2026 | MESSEMER DEBORAH M. | director | A-Award | Acquired | 95,400 | $0.00 |
| 23 Jun 2026 | Mayo Stephen | director | A-Award | Acquired | 144,400 | $2.00 |
| 23 Jun 2026 | SATO VICKI L | director | A-Award | Acquired | 95,400 | $0.00 |
| 23 Jun 2026 | WITTE OWEN N. | director | A-Award | Acquired | 95,400 | $0.00 |
| 23 Jun 2026 | Humer Franz B | director | A-Award | Acquired | 95,400 | $0.00 |